✦ LIBER ✦

Drug-induced reduction in estimated glomerular filtration rate in patients with ALK-positive non-small cell lung cancer treated with the ALK inhibitor crizotinib

✍ Scribed by Brosnan, Evelyn M.; Weickhardt, Andrew J.; Lu, Xian; Maxon, Delee A.; Barón, Anna E.; Chonchol, Michel; Camidge, D. Ross

Book ID: 126607629
Publisher: John Wiley and Sons
Year: 2013
Tongue: English
Weight: 520 KB
Volume: 120
Category: Article
ISSN: 0008-543X
DOI: 10.1002/cncr.28478

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Severe Acute Interstitial Lung Disease A

Severe Acute Interstitial Lung Disease After Crizotinib Therapy in a Patient With EML4-ALK-Positive Non-Small-Cell Lung Cancer

✍ Tamiya, A.; Okamoto, I.; Miyazaki, M.; Shimizu, S.; Kitaichi, M.; Nakagawa, K. 📂 Article 📅 2013 🏛 American Society of Clinical Oncology 🌐 English ⚖ 819 KB

Overcoming the resistance to Crizotinib

Overcoming the resistance to Crizotinib in patients with Non-Small Cell Lung Cancer harboring EML4/ALK translocation

✍ Perez, Cesar A.; Velez, Michel; Raez, Luis E.; Santos, Edgardo S. 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 868 KB

Activity and safety of crizotinib in pat

Activity and safety of crizotinib in patients with ALK-positive non-small-cell lung cancer: updated results from a phase 1 study

✍ D Ross Camidge; Yung-Jue Bang; Eunice L Kwak; A John Iafrate; Marileila Varella- 📂 Article 📅 2012 🏛 The Lancet 🌐 English ⚖ 310 KB

369 Timing of responses to crizotinib (P

369 Timing of responses to crizotinib (PF-02341066) in anaplastic lymphoma kinase (ALK)-positive patients with advanced non-small cell lung cancer (NSCLC)

✍ B. Solomon; Y.J. Bang; D.R. Camidge; A.J. Iafrate; E.L. Kwak; R.G. Maki; S.I. Ou 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 45 KB

Cost-Effectiveness of EML4-ALK Fusion Te

Cost-Effectiveness of EML4-ALK Fusion Testing and First-Line Crizotinib Treatment for Patients with Advanced ALK Positive Non-Small Cell Lung Cancer in a Publicly Funded System (Ontario, Canada)

✍ Djalalov, S.; Beca, J.; Hoch, J.S.; Krahn, M.D.; Tsao, M.S.; Cutz, J.C.; Leighl, 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 61 KB

Effect of crizotinib on overall survival

Effect of crizotinib on overall survival in patients with advanced non-small-cell lung cancer harbouring ALK gene rearrangement: a retrospective analysis

✍ Alice T Shaw; Beow Y Yeap; Benjamin J Solomon; Gregory J Riely; Justin Gainor; J 📂 Article 📅 2011 🏛 The Lancet 🌐 English ⚖ 250 KB